The Clearspace-1 mission is due to launch in 2026, but its target may have smashed into more space debris flying around Earth.
A European space debris cleanup mission run by the European Space Agency (ESA) and Swiss startup ClearSpace has been adversely affected by space debris.
The mission, called ClearSpace-1, is aiming to collect a Vespa payload adapter left in low Earth orbit by a Vega rocket over a decade ago.
Scientists use AI-powered brain-computer interface (BCI) to decipher speech.
Brain chips, a current research focus, are used for recording brain activity and treating several neurodegenerative diseases. In May this year, a man who lost the ability to talk because of a motorcycle incident stood up after 12 years thanks to brain implants that provided a bridge for communication between his brain and spinal cord.
Another area in which brain implants have shown significant potential is deciphering speech. Decoding brain signals to speech.
Gremlin/iStock.
The company calls it the iPhone of bots as development partners will further applications of this humanoid robot.
Texas-based Apptronik unveiled its first commercial humanoid robot designed to complement the industrial workforce by doing repetitive tasks that humans do not want to do, a press release said. The bot is pocket-friendly and aims to be interaction friendly, making it easier to work alongside humans even in some of the toughest environments, a definite competitor for Tesla’s humanoid bot Optimus.
The use of robotics in industrial workspaces is inevitable, and companies such as Amazon have already deployed them in large numbers to increase the efficiency of their operations. A … More.
SBUDNIC was a small cube satellite, about the size of a bread loaf, that was launched on a SpaceX rocket in May 2022.
Space junk is a serious issue that threatens the safety and sustainability of orbital activities. To address this problem, a team of students from Brown University designed and built a low-cost cube satellite that successfully deorbited itself after completing its mission. The satellite, named SBUDNIC, used a simple plastic drag sail to increase its atmospheric drag and hasten its reentry.
As per the press release, the small cube satellite has burned up high above Turkey after 445 days in orbit. Its reentry into Earth’s atmosphere on Tuesday, Aug. 8, marked the successful conclusion of a low-cost experiment aimed at reducing space debris, five years ahead of schedule.
The team conceptualized this robot based on real dogs’ motor control processes.
Robotic dogs are considered valuable future assets in various fields, including warfare, package delivery services, and search and rescue operations, to name a few. And the ones with the dexterity to navigate on extremely rough terrain could be game-changers for future space exploration.
A team of engineers has unveiled a dog-inspired quadruped robot adept at running without aid or even motors. This distinguishes this prototype from others that rely on control motors to maintain their running stride.
Only five bots will be made and are priced at $2.5 million a piece.
Japanese company Tsubame pulls this straight from science fiction and makes Transformer-like mecha robots. The first, dubbed Archax, has a cockpit where a human can sit to pilot the bot and, at the touch of a button, can even take a different form. Although not with the finesse, the Autobots manage with animation in the movie franchise.
Fans of Japanese culture might be aware of the importance of giant mechanical robots in the country’s entertainment scene and how they have become a genre in themselves. Japanese companies, known for their expertise in robotics, have also delved into building real-world replicas of these, but nothing constructed so far has come as close to what Tsubame has achieved.
Two studies report considerable improvements in technologies designed to help people with facial paralysis to communicate.
To address the HIV surveillance needs of the global community, the Applied Biosystems HIV-1 Genotyping Kit with Integrase offers broad genotyping coverage of HIV-1 Group M subtypes from extracted viral RNA from plasma and dried blood spot (DBS) samples to detect resistance to protease inhibitors, nucleoside reverse-transcriptase inhibitors, non-nucleoside reverse-transcriptase inhibitors, and integrase inhibitors.
This HIV-1 resistance kit harnesses gold-standard Sanger sequencing technology to amplify and reliably sequence the diverse and rapidly evolving HIV-1 virus.
This product employs assays for HIV-1 genotyping licensed from the U.S. Centers for Disease Control and Prevention.
Are you looking for an AI platform that can help you build modern applications? Look no further than our selection of top performing platforms!
“Microglia exhibit both maladaptive and adaptive roles in the pathogenesis of neurodegenerative diseases and have emerged as a therapeutic target for central nervous system (CNS) disorders, including those affecting the retina,” wrote the researchers. “Replacing maladaptive microglia, such as those impacted by aging or over-activation, with exogenous microglia that enable adaptive functions has been proposed as a potential therapeutic strategy for neurodegenerative diseases. To investigate the potential of microglial cell replacement as a strategy for retinal diseases, we first employed an efficient protocol to generate a significant quantity of human-induced pluripotent stem cells (hiPSC)-derived microglia.”
“Our understanding of microglia function comes predominantly from rodent studies due to the difficulty of sourcing human tissue and isolating the microglia from these tissues. But there are genetic and functional differences between microglia in mice and humans, so these studies may not accurately represent many human conditions,” explained lead author Wenxin Ma, a PhD, biologist at the Retinal Neurophysiology Section, National Eye Institute, National Institutes of Health.
“To address this concern, researchers have been growing human microglia from human stem cells. We wanted to take this a step further and see if we could transplant human microglia into the mouse retina, to serve as a platform for screening therapeutic drugs as well as explore the potential of microglia transplantation as a therapy itself,” added senior author Wai Wong, vice president of retinal disease, Janssen Research and Development.
